FBC
IRMD icon

Fairfield, Bush & Co’s iRadimed IRMD Stock Holding History

Fairfield, Bush & Co’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-33
Closed -$1.57K – 279
2023
Q4 		$1.57K Buy
+33
New +$1.39K ﹤0.01% 406
2023
Q3 		– Sell
-33
Closed -$1.57K – 292
2023
Q2 		$1.57K Buy
+33
New +$1.49K ﹤0.01% 434
2022
Q3 		– Sell
-33
Closed -$1K – 271
2022
Q2 		$1K Buy
+33
New +$1.18K ﹤0.01% 424

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
BCM
Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fairfield, Bush & Co's IRMD Position: Q1 2024 in Review

Fairfield, Bush & Co sold out of iRadimed (IRMD) in Q1 2024, closing a stake of 33 shares — an estimated $1.57K sold.

Fairfield, Bush & Co first reported a position in IRMD in Q2 2022 and held it in 3 quarters. The position peaked at $1.57K in Q2 2023. 126 funds tracked by Wall St. Rank hold IRMD as of Q1 2024.

  • Fairfield, Bush & Co reported no remaining iRadimed position as of Q1 2024 after selling out during the quarter.
  • Fairfield, Bush & Co sold 33 iRadimed shares in Q1 2024, an estimated $1.57K.
  • Fairfield, Bush & Co first reported a position in iRadimed in Q2 2022 and held it in 3 quarters.
  • Fairfield, Bush & Co's iRadimed position peaked at $1.57K in Q2 2023.
  • 126 funds tracked by Wall St. Rank held iRadimed as of Q1 2024.

Based on Fairfield, Bush & Co's 13F filing for Q1 2024, filed 15 May 2024.